The State of Sports Medicine 2025

Sports medicine is a lucrative $7 billion segment with an attractive growth profile. Arthrex and Smith+Nephew dominate the space, accounting for more than half of all sports medicine sales. Stryker and Johnson & Johnson MedTech are the only other sports medicine players with double-digit share. Combined, the top four players in sports medicine control 80% of the market.

The segment also lacks the M&A and innovation cadence seen in some other segments. In this video we dive into where sports medicine might go next.

Mike Evers is an analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage. You can reach him by email.

3 Additional Resources
Orthopedic Market Size and Share by Segment

Orthopedic Companies Sales Matrix

THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT®